211 related articles for article (PubMed ID: 8781910)
1. Lack of association between porphyria cutanea tarda and alpha 1-antitrypsin deficiency.
Fargion S; Sergi C; Bissoli F; Fracanzani AL; Suigo E; Carazzone A; Roberto C; Cappellini MD; Fiorelli G
Eur J Gastroenterol Hepatol; 1996 Apr; 8(4):387-91. PubMed ID: 8781910
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of hepatitis C virus type 1b in Italian patients with Porphyria cutanea tarda.
Sampietro M; Fracanzani AL; Corbetta N; Amato M; Mattioli M; Molteni V; Fiorelli G; Fargion S
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):543-7. PubMed ID: 9513830
[TBL] [Abstract][Full Text] [Related]
3. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association.
Fargion S; Piperno A; Cappellini MD; Sampietro M; Fracanzani AL; Romano R; Caldarelli R; Marcelli R; Vecchi L; Fiorelli G
Hepatology; 1992 Dec; 16(6):1322-6. PubMed ID: 1359994
[TBL] [Abstract][Full Text] [Related]
5. [Role of hepatitis C virus in porphyria cutanea tarda hepatopathy].
Quecedo L; Costa J; Enríquez de Salamanca R
Med Clin (Barc); 1996 Mar; 106(9):321-4. PubMed ID: 8667696
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
[TBL] [Abstract][Full Text] [Related]
7. Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled study.
Stölzel U; Schuppan D; Tillmann HL; Manns MP; Tannapfel A; Doss MO; Zimmer T; Köstler E
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):43-7. PubMed ID: 11929046
[TBL] [Abstract][Full Text] [Related]
8. Familial and sporadic porphyria cutanea tarda: clinical and biochemical features and risk factors in 152 patients.
Muñoz-Santos C; Guilabert A; Moreno N; To-Figueras J; Badenas C; Darwich E; Herrero C
Medicine (Baltimore); 2010 Mar; 89(2):69-74. PubMed ID: 20517178
[TBL] [Abstract][Full Text] [Related]
9. The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients.
Stuart KA; Busfield F; Jazwinska EC; Gibson P; Butterworth LA; Cooksley WG; Powell LW; Crawford DH
J Hepatol; 1998 Mar; 28(3):404-9. PubMed ID: 9551677
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of hepatitis C in patients with porphyria cutanea tarda in Stockholm, Sweden.
Linde Y; Harper P; Floderus Y; Ros AM
Acta Derm Venereol; 2005; 85(2):164-6. PubMed ID: 15823914
[TBL] [Abstract][Full Text] [Related]
11. Genetic hemochromatosis in Italian patients with porphyria cutanea tarda: possible explanation for iron overload.
Fargion S; Fracanzani AL; Romano R; Cappellini MD; Faré M; Mattioli M; Piperno A; Ronchi G; Fiorelli G
J Hepatol; 1996 May; 24(5):564-9. PubMed ID: 8773911
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda.
DeCastro M; Sánchez J; Herrera JF; Cháves A; Durán R; García-Buey L; García-Monzón C; Sequí J; Moreno-Otero R
Hepatology; 1993 Apr; 17(4):551-7. PubMed ID: 7682979
[TBL] [Abstract][Full Text] [Related]
13. Association of porphyria cutanea tarda with hereditary hemochromatosis.
Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR
J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
[TBL] [Abstract][Full Text] [Related]
14. Association between porphyria cutanea tarda and beta-thalassemia major.
Barbieri L; Macrì A; Lupia Palmieri G; Aurizi C; Biolcati G
Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):36-9. PubMed ID: 19656449
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of hepatitis C virus infection in Japanese patients with porphyria cutanea tarda.
Kondo M; Horie Y; Okano J; Kitamura A; Maeda N; Kawasaki H; Mishiro S; Yamamoto S; Itou T; Saeki S; Tanaka S; Okamoto H
Hepatology; 1997 Jul; 26(1):246. PubMed ID: 9214482
[No Abstract] [Full Text] [Related]
16. Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection.
Martinelli AL; Zago MA; Roselino AM; Filho AB; Villanova MG; Secaf M; Tavella MH; Ramalho LN; Zucoloto S; Franco RF
Am J Gastroenterol; 2000 Dec; 95(12):3516-21. PubMed ID: 11151887
[TBL] [Abstract][Full Text] [Related]
17. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda].
Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M
Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743
[TBL] [Abstract][Full Text] [Related]
18. [Association of cirrhosis and hepatocellular carcinoma with porphyria cutanea tarda].
Ishibashi H; Matsunaga T; Dohmen K
Nihon Rinsho; 1995 Jun; 53(6):1474-8. PubMed ID: 7616664
[TBL] [Abstract][Full Text] [Related]
19. [Porphyria cutanea tarda--new views on its pathogenesis and therapy].
Falkiewicz B; Dabrowska E; Jabłońska-Kaszewska I
Wiad Lek; 1997; 50(4-6):106-11. PubMed ID: 9381711
[TBL] [Abstract][Full Text] [Related]
20. Development of porphyria cutanea tarda in a hemodialysis patient after reactivation of hepatitis C virus infection.
Albalate M; Fariñas MC; Octavio JG; Perez JH; Goicoechea M; Caramelo C
Nephron; 2001 Jun; 88(2):170-3. PubMed ID: 11399922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
